Prospective, placebo-controlled clinical trial with Aconite Pain Oil in oncological patients undergoing chemotherapy to prevent chemotherapy-induced polyneuropathy (CIPN) grade II, to reduce symptoms typical of CIPN and to improve the quality of life of patients with CIPN
